|5.33||+0.09 / +1.72%|
As of 4:00pm ET
|5.33||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +190.81% increase from the last price of 5.33.
The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.